PLATINUM INVESTMENT MANAGEMENT LTD
Position in ABSI — Absci Corp
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in ABSI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$713,292
-$116,504 QoQ
Shares Held
237,764
0.0% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $70,718,725 across 29 Biotechnology names. ABSI ranks #27 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
110,734 | $5,837,896 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
137,741 | $5,471,072 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $4,908,289 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,573,628 | |
| 5 | IMVT |
Immunovant, Inc.
|
181,774 | $4,515,266 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
112,066 | $4,313,420 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $4,059,950 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
49,269 | $3,658,715 |
All Filings in ABSI
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $713,292 | 237,764 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $829,796 | 237,764 | Shares | Sole | 2026-02-13 | |
| 2024-12-31 | $1,444,112 | 551,188 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,747,279 | 457,403 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,634,500 | 530,682 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,411,099 | 776,602 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,517,903 | 837,596 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,724,801 | 1,306,668 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,986,135 | 1,306,668 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,017,667 | 581,524 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $667,321 | 317,772 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $994,626 | 317,772 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $988,772 | 297,823 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,510,647 | 297,823 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,442,148 | 297,823 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,344,322 | 287,560 | Shares | Sole | 2021-11-09 | |
| No filing history on record for this holder in this stock. | ||||||